{"id":"W2023850571","doi":"10.1038/psp.2013.22","title":"Dose Response and Pharmacokinetics of Tofacitinib (CP‐690,550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis","year":2013,"lang":"en","type":"article","venue":"CPT Pharmacometrics & Systems Pharmacology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"Pfizer","keywords":"Tofacitinib; Janus kinase inhibitor; Medicine; Psoriasis; Pharmacokinetics; Clinical trial; Placebo; Population; Pharmacology; Plaque psoriasis; Internal medicine; Covariate; Dosing; Dermatology; Rheumatoid arthritis; Statistics; Pathology; Mathematics","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001330091,0.0006222661,0.001202252,0.001615964,0.0001766865,0.0000363636,0.000620508,0.0004174188,0.0008340318],"category_scores_gemma":[0.00006185883,0.0004684704,0.000228764,0.001928749,0.0004797623,0.0002824064,0.0000935111,0.0003357793,0.00009087227],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003284515,"about_ca_system_score_gemma":0.0002378552,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009353866,"about_ca_topic_score_gemma":0.00001649673,"domain_scores_codex":[0.9936917,0.003290813,0.001299044,0.0006917402,0.0001831698,0.000843521],"domain_scores_gemma":[0.9965354,0.001930942,0.0006377256,0.0004789955,0.0002744227,0.0001425013],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003062321,0.004164498,0.009222901,0.0002082471,0.0009819536,0.0001054919,0.002423543,0.0001217001,0.915054,0.00005061546,0.003249109,0.06135565],"study_design_scores_gemma":[0.03538133,0.006254511,0.0183979,0.00005568559,0.001559014,0.0002758107,0.001070722,0.0004829966,0.8324315,0.00002014752,0.1033619,0.0007084476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9590135,0.03357527,0.00001839639,0.0002255416,0.003996558,0.002444096,0.0005626555,0.00005852942,0.0001054493],"genre_scores_gemma":[0.9909691,0.007224418,0.00004068514,0.0001299345,0.0002904875,0.0007893198,0.0001751181,0.00005225915,0.0003287346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1001128,"threshold_uncertainty_score":0.9997767,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03613601634449804,"score_gpt":0.3093371664949287,"score_spread":0.2732011501504306,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}